Jianfei Sun | Biosensing and Bioimaging | Best Researcher Award

Prof. Jianfei Sun | Biosensing and Bioimaging | Best Researcher Award

Southeast University | China

Publication Profile:

Google Scholar

๐Ÿ‘จโ€๐ŸŽ“ Summary:

Prof. Jianfei Sun is a distinguished researcher and doctoral supervisor at Southeast University, China. He specializes in magnetic nanomaterials for medicine and electromagnetic therapy. As the director of the Jiangsu Key Laboratory of Biomaterials and Devices, he has pioneered methods for overcoming depth limitations in medical treatments using magnetic stimulation. With over 90 academic papers and 9 invention patents, Prof. Sun’s work has contributed significantly to both scientific advancements and technology transfer.

๐ŸŽ“ Education:

Prof. Sun holds a doctoral degree in a relevant field and has completed extensive research in biomaterials and electromagnetic therapies.

๐Ÿ’ผ Professional Experience:

Prof. Sun has a notable academic career at Southeast University, where he supervises doctoral students and leads cutting-edge research in biomedical engineering. His work focuses on developing advanced magnetic nanomaterials for medical applications and their integration into clinical therapies.

๐Ÿ“š Academic Citations:

Prof. Sun has authored over 90 papers published in renowned academic journals, including key publications in Zoological Research, ACS Applied Materials & Interfaces, and Applied Physics A. His research has been widely cited, making a significant impact in the field of medical magnetism.

๐Ÿ› ๏ธ Technical Skills:

  • Magnetic Nanomaterial Synthesis

  • Electromagnetic Therapy Development

  • Precision Magnetic Stimulation

  • Biomaterial Application in Medicine

  • Patented Technology in Nanotechnology

๐Ÿ‘จโ€๐Ÿซ Teaching Experience:

Prof. Sun has contributed to academia as a doctoral supervisor at Southeast University, mentoring students in the fields of biomaterials, nanotechnology, and medical engineering.

๐Ÿ”ฌ Research Interests:

His research is centered on the application of magnetic nanomaterials in medicine, particularly in electromagnetic therapies for neurological diseases. Prof. Sunโ€™s pioneering work includes precision magnetic stimulation methods and nano-iron oxide materials used for therapeutic purposes.

๐Ÿ“šย Top Notes Publications:

Co-seismic ruptures of the 12 May 2008, Ms 8.0 Wenchuan earthquake, Sichuan: Eastโ€“west crustal shortening on oblique, parallel thrusts along the eastern edge of Tibet
    • Authors: J Liu-Zeng, Z Zhang, L Wen, P Tapponnier, J Sun, X Xing, G Hu, Q Xu, …

    • Journal: Earth and Planetary Science Letters

    • Year: 2009

Response of MAPK pathway to iron oxide nanoparticles in vitro treatment promotes osteogenic differentiation of hBMSCs
    • Authors: Q Wang, B Chen, M Cao, J Sun, H Wu, P Zhao, J Xing, Y Yang, X Zhang, …

    • Journal: Biomaterials

    • Year: 2016

Magnetic field and nano-scaffolds with stem cells to enhance bone regeneration
    • Authors: Y Xia, J Sun, L Zhao, F Zhang, XJ Liang, Y Guo, MD Weir, MA Reynolds, …

    • Journal: Biomaterials

    • Year: 2018

A novel magnetic hydrogel with aligned magnetic colloidal assemblies showing controllable enhancement of magnetothermal effect in the presence of alternating magnetic field
    • Authors: K Hu, J Sun, Z Guo, P Wang, Q Chen, M Ma, N Gu

    • Journal: Advanced Materials

    • Year: 2015

Effect of drip irrigation on strawberry growth and yield inside a plastic greenhouse
    • Authors: BZ Yuan, J Sun, S Nishiyama

    • Journal: Biosystems Engineering

    • Year: 2004

Tacrineโ€“ferulic acidโ€“nitric oxide (NO) donor trihybrids as potent, multifunctional acetyl-and butyrylcholinesterase inhibitors
    • Authors: Y Chen, J Sun, L Fang, M Liu, S Peng, H Liao, J Lehmann, Y Zhang

    • Journal: Journal of Medicinal Chemistry

    • Year: 2012

Cuihong Tian | Healthcare Data Analysis | Best Researcher Award

Dr. Cuihong Tian | Healthcare Data Analysis | Best Researcher Award

First Affiliated Hospital of Shantou University Medical College | China

PUBLICATION PROFILE

Scopus

Orcid

Dr. Cuihong Tianโšก๐ŸŒ

INTRODUCTION ๐ŸŒŸ

Dr. Tian Cuihong is a highly accomplished physician and researcher specializing in cardiovascular medicine. Currently, she holds a postdoctoral research position at Shantou University Medical College. With a strong foundation in clinical practice and a deep commitment to scientific exploration, Tianโ€™s research focuses on the molecular mechanisms behind cardiovascular diseases and the role of glycosylation in atherosclerosis. She has made a significant impact in her field through both her research and clinical practice. ๐ŸŒŸ

EARLY ACADEMIC PURSUITS ๐ŸŽ“

Tianโ€™s academic journey began at Shandong Second Medical University, where she earned her Bachelor’s degree in Clinical Medicine in 2016. Following this, she pursued a Masterโ€™s degree in Internal Medicine at Xiangya Medical College, Central South University. In 2019, Tian advanced her studies with a Doctorate in Natural and Physical Sciences from Edith Cowan University in Australia. During this time, she focused on glycobiology and its critical role in human health. ๐ŸŽ“

PROFESSIONAL ENDEAVORS ๐Ÿ’ผ

From 2019 to 2024, Tian worked as a physician at the Cardiovascular Hospital of the First Affiliated Hospital of Shantou University Medical College. Her work involved patient care, as well as contributing to cardiovascular research. Since March 2024, she has been a postdoctoral researcher at Shantou University Medical College, where she continues her exploration of the molecular underpinnings of cardiovascular diseases, particularly through the lens of glycosylation. ๐Ÿ’ผ

CONTRIBUTIONS AND RESEARCH FOCUSย  ON Healthcare Data Analysis๐Ÿ”ฌ

Tianโ€™s research primarily investigates the role of immunoglobulin G N-glycosylation in atherosclerosis and its correlation with cardiovascular events. She received significant funding from Guangdongโ€™s Science and Technology Department for her research on this subject. Her studies aim to provide better diagnostic tools and therapeutic strategies for cardiovascular diseases, with an emphasis on molecular mechanisms. ๐Ÿ”ฌ

IMPACT AND INFLUENCE ๐ŸŒ

Dr. Tian Cuihong has had a profound impact on the scientific community. Her groundbreaking research in glycobiology and cardiovascular medicine has contributed to a deeper understanding of the molecular pathways in cardiovascular disease. Her work on the role of glycosylation in cardiovascular health has been widely recognized, influencing future research and offering novel insights for improving patient care. ๐ŸŒ

ACADEMIC CITATIONS AND PUBLICATIONS ๐Ÿ“š

Tian has authored and co-authored several impactful research articles, published in prestigious journals such as BMJ Open, EPMA Journal, and J Global Health. Some of her significant works include studies on the association between immunoglobulin G N-glycosylation and carotid atherosclerosis, and her contributions to understanding COVID-19 testing accuracy. These publications have been highly cited and continue to influence the scientific community. ๐Ÿ“š

HONORS & AWARDS ๐Ÿ…

Throughout her career, Tian Cuihong has been recognized for her exceptional contributions to science. She has received several honors and awards for her work in cardiovascular research and glycosylation studies. Her dedication to improving diagnostic methods and patient care in cardiovascular medicine has earned her recognition within both academic and clinical circles. ๐Ÿ…

LEGACY AND FUTURE CONTRIBUTIONS ๐Ÿ”ฎ

Looking ahead, Tian Cuihongโ€™s contributions to cardiovascular medicine and molecular biology are set to continue shaping the future of the field. Her ongoing research holds the potential to revolutionize diagnostic practices and treatment strategies for cardiovascular diseases. As her work progresses, she will likely leave a lasting legacy in the medical community. ๐Ÿ”ฎ

FINAL NOTE โœจ

Tian Cuihongโ€™s career is a remarkable blend of clinical practice and scientific research. Her groundbreaking work in understanding the molecular mechanisms of cardiovascular diseases continues to make waves in the medical world. With her continued dedication, Tianโ€™s future contributions promise to have a lasting impact on both research and patient care. โœจ

TOP NOTES PUBLICATIONSย ๐Ÿ“š

Impacts of Molecular Drivers in Aortic Dissection
  • Authors: Cuihong Tian, Yequn Chen, Xuerui Tan
  • Journal: Clinical and Translational Discovery
  • Year: 2024

Association of Triglyceride-Glucose Index with the Risk of Incident Aortic Dissection and Aneurysm: A Large-Scale Prospective Cohort Study in UK Biobank
  • Authors: Cuihong Tian, Yequn Chen, Binyi Xu, Xuerui Tan, Zhaowei Zhu
  • Journal: Cardiovascular Diabetology
  • Year: 2024

Effectiveness of a Standardized Quality Control Management Procedure for COVID-19 RT-PCR Testing: A Large-Scale Diagnostic Accuracy Study in China
  • Authors: Mengyu Liu, Cuihong Tian, Yequn Chen, Jinxiu Zhu, Yan Zheng, Jianhua Chen, Zhen Li, Feng Xu, Liang Wu, Xingyu Wang et al.
  • Journal: Diagnostic Microbiology and Infectious Disease
  • Year: 2024

Pelvic Infection Caused by Periodontitis: A Case Report
  • Authors: Cuihong Tian, Hongle Yan, Ping Tang, Jinqiu Shi, Maolian Liang, Yanyan Wan, Weiping Li, Xizhuo Sun, Chenglu Qin
  • Journal: Case Reports in Women’s Health
  • Year: 2023

Validity and Reliability of the Persian Version of the Suboptimal Health Status Questionnaire Among University Staff in Iran
  • Authors: Erfan Ayubi, Salman Khazaei, Shiva Borzouei, Ali Reza Soltanian, Samereh Ghelichkhani, Fatemeh Karbin, Yuxiang Yan, Manshu Song, Cuihong Tian, Wei Zhang et al.
  • Journal: Journal of Global Health
  • Year: 2023

 

Laurence Vaughan | Medical Diagnostics | Best Researcher Award

Dr. Laurence Vaughan | Medical Diagnostics | Best Researcher Award

Dr. Laurence Vaughan at Becton Dickinson and Company, United States

๐Ÿ‘จโ€๐ŸŽ“ Professional Profile

๐ŸŽ“ Early Academic Pursuits

Dr. Laurence Vaughan began his academic journey at the University of Dublin, Trinity College, where he earned a BA (Honors) in Natural Sciences (Genetics) in 1986, followed by a Ph.D. in Molecular Microbiology in 1991. His doctoral research focused on the aroA gene of Aeromonas salmonicida, contributing to foundational knowledge in microbiology and vaccine development.

๐Ÿข Professional Endeavors

Dr. Vaughanโ€™s career spans over three decades in the biotechnology and molecular diagnostics sectors. Currently, he serves as the Director of Scientific Affairs at Becton Dickinson and Company, focusing on integrated diagnostic solutions for womenโ€™s health, particularly cervical cancer screening. His past roles include R&D leadership at QIAGEN and Corning Incorporated, where he made significant advancements in molecular assay development and product support.

๐ŸŒŸ Contributions and Research Focus

Dr. Vaughan has led teams in developing groundbreaking products such as the BD Onclarity cervical cancer screening test, which received CE Mark approval in 2014 and US-PMA approval in 2018. He has authored content for international conferences and peer-reviewed publications, emphasizing his commitment to advancing scientific knowledge and product innovation in the diagnostics field.

๐ŸŒ Impact and Influence

His work has not only shaped diagnostic guidelines but has also influenced industry standards, as seen with the American Society for Colposcopy and Cervical Pathology (ASCCP) management guidelines launched in 2020. Dr. Vaughan’s expertise is recognized internationally, making him a sought-after speaker at various conferences.

๐Ÿ“š Academic Cites

Dr. Vaughan has made notable contributions to the field of vaccinology, evidenced by multiple patents and publications. His editorial experience as the Editor-in-Chief of “Diseases of Aquatic Organisms” from 1995 to 1999 further underscores his leadership in academic discourse.

๐Ÿ”ง Technical Skills

Dr. Vaughan possesses extensive technical skills in molecular biology, microbiology, and genetics. His proficiency in managing clinical trials, particularly in the R&D lead for Onclarity HPV clinical trials, highlights his ability to oversee complex scientific projects.

๐Ÿ‘ฉโ€๐Ÿซ Teaching Experience

Throughout his career, Dr. Vaughan has demonstrated a passion for education and mentorship. He has developed and delivered training for global customers and internal teams, showcasing his strong communication and interpersonal skills.

๐Ÿ… Legacy and Future Contributions

Dr. Vaughan’s legacy includes a robust portfolio of innovations and leadership in the biotech field. His achievements, such as the Becton Dickinson Wesley J. Howe Award for Technological Innovation in 2013, reflect his dedication to advancing science and technology. Looking ahead, he aims to continue contributing to the development of effective diagnostic solutions and vaccines, focusing on emerging health challenges.

 

๐Ÿ“– Top Noted Publications

Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening

Authors: Vaughan, L., Gary, D., Shah, M., Galbraith, L., Parvu, V.
Journal: Gynecologic Oncology Reports
Year: 2024

Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial

Authors: Stoler, M.H., Parvu, V., Yanson, K., Andrews, J., Vaughan, L.
Journal: Gynecologic Oncology
Year: 2023

Validation of a New High-Throughput BD COR System Using the BD CTGCTV2 Assay

Authors: Taylor, S., Rucki, A., Lockamy, E., Vaughan, L., Greene, W.
Journal: Journal of Molecular Diagnostics
Year: 2022

Evaluation of the Onclarity HPV assay on the high-throughput COR system

Authors: Taylor, S.N., Eckert, K., Rucki, A.A., Vaughan, L.M., Greene, W.H.
Journal: Expert Review of Molecular Diagnostics
Year: 2021

Cotesting in cervical cancer screening

Authors: Malinowski, D.P., Broache, M., Vaughan, L., Andrews, J., Gary, D.
Journal: American Journal of Clinical Pathology
Year: 2021

Analytical and clinical sample performance characteristics of the onclarity assay for the detection of human papillomavirus

Authors: Young, S., Vaughan, L., Yanson, K., Cooper, C.K., van der Pol, B.
Journal: Journal of Clinical Microbiology
Year: 2021